Abstract
This chapter focuses on the clinical presentation, diagnosis, treatment options, and long-term prognosis of acute postoperative infection utilizing both retrospective and prospective data ranging from 1975 to 2017.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control. 1992;20(5):271–4.
Piper KE, Fernandez-Sampedro M, Steckelberg KE, et al. C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One. 2010;5(2):e9358.
Olszewski D, Streubel PN, Stucken C, et al. Fate of patients with a “surprise” positive culture after nonunion surgery. J Orthop Trauma. 2016;30(1):e19–23.
Aggarwal VK, Higuera C, Deirmengian G, Parvizi J, Austin MS. Swab cultures are not as effective as tissue cultures for diagnosis of periprosthetic joint infection. Clin Orthop Relat Res. 2013;471(10):3196–203.
Gitajn IL, Heng M, Weaver MJ, Ehrlichman LK, Harris MB. Culture-negative infection after operative fixation of fractures. J Orthop Trauma. 2016;30(10):538–44.
Stucken C, Olszewski DC, Creevy WR, Murakami AM, Tornetta P. Preoperative diagnosis of infection in patients with nonunions. J Bone Joint Surg. 2013;95(15):1409–12.
Gefen O, Balaban NQ. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev. 2009;33(4):704–17.
Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007;5(1):48–56.
Cierny G 3rd, Mader JT, Penninck JJ. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res. 2003;(414):7–244.
Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD, Team I. Patient-related risk factors for Periprosthetic joint infection after Total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150866.
Maoz G, Phillips M, Bosco J, et al. The Otto Aufranc award: modifiable versus nonmodifiable risk factors for infection after hip arthroplasty. Clin Orthop Relat Res. 2015;473(2):453–9.
Vergidis P, Patel R. Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections. Infect Dis Clin N Am. 2012;26(1):173–86.
Trampuz A, Zimmerli W. Diagnosis and treatment of infections associated with fracture-fixation devices. Injury. 2006;37(Suppl 2):S59–66.
Trebse R, Pisot V, Trampuz A. Treatment of infected retained implants. J Bone Joint Surg. 2005;87(2):249–56.
Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350(14):1422–9.
Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001;33(Suppl 2):S94–106.
Rightmire E, Zurakowski D, Vrahas M. Acute infections after fracture repair: management with hardware in place. Clin Orthop Relat Res. 2008;466(2):466–72.
Berkes M, Obremskey WT, Scannell B, et al. Maintenance of hardware after early postoperative infection following fracture internal fixation. J Bone Joint Surg Am. 2010;92(4):823–8.
Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly. 2005;135(17–18):243–51.
Meehan AM, Osmon DR, Duffy MC, Hanssen AD, Keating MR. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. Clin Infect Dis. 2003;36(7):845–9.
Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78(4):512–23.
Francino MP. Antibiotics and the human gut microbiome: Dysbioses and accumulation of resistances. Front Microbiol. 2015;6:1543.
Craig WA, Andes DR. Parenteral versus oral antibiotic therapy. Med Clin N Am. 1995;79(3):497–508.
Green S. Efficacy of oral fleroxacin in bone and joint infections. Am J Med. 1993;94(3A):174S–6S.
Jones RN, Beach ML, Pfaller MA, Doern GV. Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in north and South America. Diagn Microbiol Infect Dis. 1998;32(3):247–52.
Putz P. A pilot study of oral fleroxacin given once daily in patients with bone and joint infections. Am J Med. 1993;94(3A):177S–81S.
Torbert JT, Joshi M, Moraff A, et al. Current bacterial speciation and antibiotic resistance in deep infections after operative fixation of fractures. J Orthop Trauma. 2015;29(1):7–17.
Galanakis N, Giamarellou H, Moussas T, Dounis E. Chronic osteomyelitis caused by multi-resistant gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother. 1997;39(2):241–6.
Lew DP, Waldvogel FA. Quinolones and osteomyelitis: state-of-the-art. Drugs. 1995;49(2):100–11.
Rissing JP. Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones. Clin Infect Dis. 1997;25(6):1327–33.
Mader J, Cantrell J, Calhoun J. Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults. J Bone Joint Surg Am. 1990;72(1):104–10.
Gentry L, Rodriguez G. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob Agents Chemother. 1990;34(1):40–3.
Swiontkowski M, Hanel DP, Vedder N, Schwappach JA. Comparison of short-and long-term intravenous antibiotic therapy in the postoperative management of adult osteomyelitis. J Bone Joint Surg Br. 1999;81(6):1046–50.
Gilbert DN, Dworkin RJ, Raber SR, Leggett JE. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med. 1997;337(12):829–39.
Good Rx Web site. https://www.goodrx.com/linezolid?kw=price&utm_source=bing&utm_medium=cpc&utm_term=%252Blinezolid%2520%252Bcost&utm_campaign=linezolid&utm_content=Ad-Group_Price2016.
Soriano A, Gomez J, Gomez L, et al. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis. 2007;26(5):353–6.
Euba G, Lora-Tamayo J, Murillo O, et al. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to enterococcus faecalis. Antimicrob Agents Chemother. 2009;53(10):4305–10.
Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant–related staphylococcal infections: a randomized controlled trial. JAMA. 1998;279(19):1537–41.
Trebse R, Pisot V, Trampuz A. Treatment of infected retained implants. Bone Joint J. 2005;87(2):249–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Avilucea, F.R. (2018). Management of Acute Postoperative Infection. In: Sethi, M., Obremskey, W., Jahangir, A. (eds) Orthopedic Traumatology. Springer, Cham. https://doi.org/10.1007/978-3-319-73392-0_33
Download citation
DOI: https://doi.org/10.1007/978-3-319-73392-0_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73391-3
Online ISBN: 978-3-319-73392-0
eBook Packages: MedicineMedicine (R0)